Bharat Biotech fields for nasal vaccine to DCGI

▴ Bharat Biotech fields for nasal vaccine to DCGI
After USA now nasal vaccine may hit India

Bharat Biotech has sent a proposal to the Drugs Controller General of India (DCGI) to seek its approval for trials of a nasal vaccine against Covid-19. Bharat Biotech has been working on a nasal vaccine apart from Covaxin, which has already been approved for emergency use in India.

Hyderabad-based vaccine maker Bharat Biotech is all set to start Phase 1 and 2 trials of its nasal vaccine at Gillurkar Multi Speciality Hospital in Nagpur.

Earlier, V Krishna Mohan, executive director of Bharat Biotech, said the company is working on a nasal vaccine. Covaxin is meanwhile in its late-stage trials while it has been already approved for rollout in India.

Dr Krishna Ella, CMD of Bharat Biotech, has said, “We are working on a nasal vaccine and have partnered with the Washington University School of Medicine. We are working on a single dose vaccine compared to two-dose inactivated vaccine. Research has proven that nasal vaccine is the best choice. Coronavirus also attacks through the nose.”

Trials of the nasal vaccine will be conducted on at least 30-45 healthy volunteers above the age of 18 years at four trial sites in the country - Bhuvneshwar, Pune, Nagpur and Hyderabad. 

Tags : #BharatBiotech #NasalVaccines #DCGI #GillurkarMultiSpecialityHospital #VKrishnaMohan #KrishnaElla #Bhuvneshwar #Pune #Nagpur #Hyderabad

About the Author

Team Medicircle

Related Stories

Loading Please wait...

Trending Now

Dr. Jitender Aggarwal, Founder, and CEO, Sarthak Educational Trust presses on the need for the Government to spend more on HealthcareJanuary 25, 2021
‘’Digital consultation does not have the same impact as the physical ones,’’ says Kishor Dharmy, Personal Fitness trainerJanuary 25, 2021
Making visually impaired and blind “Atma-Nirbhar” is a challenge for India - P.V.M Rao, Faculty Member, IIT DelhiJanuary 25, 2021
Fitness of the body and mind should be a constant goal says Ishani Pimpalkhare, Freelance Yoga InstructorJanuary 25, 2021
25 millions Covid-19 cases in US, UK strain more deadly says CDCJanuary 25, 2021
India reports 13,203 fresh coronavirus cases, 131 deaths; caseload at 1.06 croreJanuary 25, 2021
India reports 13,203 fresh coronavirus cases, 131 deaths; caseload at 1.06 croreJanuary 25, 2021
India reports 13,203 fresh coronavirus cases, 131 deaths; caseload at 1.06 croreJanuary 25, 2021
Cumulative number of vaccinated healthcare workers across the country more than 16 lakhJanuary 25, 2021
More than 16 lakh people administered Covid-19 vaccines in country so far: GovtJanuary 25, 2021
There is no magic formula or easy, quick fix, but it requires consistency and effort - Shameera Somani, Masters in Food Science and NutritionJanuary 25, 2021
Decoding the best ways to lose weight with Parul Malhotra Bahl, Founder, Diet ExpressionJanuary 23, 2021
Zydus Cadila receives final approval from USFDA for Liothyronine Sodium TabletsJanuary 23, 2021
Braille can be complemented by technology and not necessarily replaced says Ketan Kothari, Manager – Advocacy, Sightsavers IndiaJanuary 23, 2021
’50 – 60% of the population have uncontrolled blood sugar levels,’’ says Dr. Abhijit Bhograj, Co-founder and CMO, 7 SugarJanuary 23, 2021
Govt. uses Rapid Assessment System, RAS for taking feedback from people vaccinated for COVID-19January 23, 2021
Cumulative number of vaccinated Healthcare Workers across the country has surpasses 12.7 lakh January 23, 2021
India's coronavirus count increases by 14,256 fresh cases; 152 deaths reported in 24 hrsJanuary 23, 2021
Pfizer and BioNTech reach agreement with COVAX for advance purchase of Vaccine to Help Combat COVID-19January 23, 2021
In life, there are no shortcuts says Honnesh Kamaria, Yoga and Fitness Instructor, TheYogaShrineJanuary 22, 2021